In life science research, data comes in many forms - structured clinical trial tables, semi-structured instrument outputs, ...
Shares in gene therapy specialist Oxford BioMedica rise 7.5 percent after the company releases data for its TroVax cancer vaccine in colorectal cancer and renal cancer at the American Society of ...
LONDON (Reuters) - Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million (77.32 million pounds) over three years for supplying the Swiss ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Oxford BioMedica ( (GB:OXB)) just ...